According to recent reports, early diabetic trial patients in pig cell experiments conducted over a decade ago are still experiencing positive effects from the experiment. The news, confirmed by surprised scientists, could lay the foundations for long-term diabetes treatments in the future.
One patient, Mr. Michael Helyer, continued to experience insulin production from pig cells injected ten years ago. Scientists, who expected transplanted cells to survive for around six months, were understandably astonished.
Professor Bob Elliott, the founder and medical director of Living Cell Technologies, based in New Zealand, said that planned human trials could result in long-term pig cell therapy becoming more widespread.
Some countries have issued moratoriums on animal-to-human transplants, including Australia, so the trials will be conducted in New Zealand and Russia . Professor Elliot commented: “This has never been done before. It’s a profound step forward for safe, effective and long-term diabetes control.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…